Nanotechnology is one of those industries that has advocates lining up for it and against it. The theoretical possibilities are endless. These could be in micro-computing, arterial plaque attacks, tissue repair, cleaning surfaces, cancer fighting, and on and on and on.
But nanotechnology also has many critics, particularly those who are concerned that nano-bots or nano particles could be used against people. In a report published in advance from NATURE NANOTECHNOLOGY, the new fear is that nanotechnology’s carbon nanotubes injected into mice showed similarities to asbestos.
The pilot study in a small number of mice shows that long multiwalled carbon nanotubes introduced into the abdominal cavity can cause asbestos-like pathogenic behavior. The results suggest the need for further research and caution before introducing nanotube products into the market.
Mesothelioma is a death sentence. If nanotech generates even the same fears, this technology may be crushed before even the simple applications can get off the ground It sounds like they need a nano-drug now, one to fight nanothelioma.
The nanotech ETF, the PowerShares Lux Nanotech (AMEX: PXN) was down 2% at $14.51, although it was on thin volume when the market itself was soft.
Jon C. Ogg
May 20, 2008
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.